Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

89 filings reported holding PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share as of Q3 2025.
Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 57.8M shares of 62.3M outstanding shares and own 92.92% of the company stock.
Largest 10 shareholders include GENERAL ATLANTIC, L.P. (8.03M shares), FMR LLC (6.4M shares), Foresite Capital Management IV, LLC (4.78M shares), venBio Partners LLC (4.64M shares), VIKING GLOBAL INVESTORS LP (3.65M shares), EQT Fund Management S.a r.l. (3.42M shares), Bain Capital Life Sciences Investors, LLC (3.18M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (2.44M shares), Commodore Capital LP (2.42M shares), and Paradigm Biocapital Advisors LP (1.84M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.